Evidence map›Paper›PMID 41350257›Full record

ArticleNature communications2025

Single cell mapping identifies a distinct platelet-phenotype in psoriatic type III inflammation.

Katharina S Kommoss, Sinduya Krishnarajah, Tabea Bieler, Ekaterina Friebel, Lukas Rindlisbacher, Pierluigi Ramadori, Philipp Häne, Shing Kam, Florian Müller, Sandra Prokosch and 11 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Katharina S Kommoss *Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID http://orcid.org/0000-0003-2428-2658
Sinduya Krishnarajah *Institute of Experimental Immunology, University of Zurich, 8057, Zurich, Switzerland.ORCID http://orcid.org/0000-0003-2348-1751
Tabea BielerDivision of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID http://orcid.org/0000-0003-3611-9305
Ekaterina FriebelInstitute of Experimental Immunology, University of Zurich, 8057, Zurich, Switzerland.ORCID http://orcid.org/0000-0003-1419-2376
Lukas RindlisbacherInstitute of Experimental Immunology, University of Zurich, 8057, Zurich, Switzerland.
Pierluigi RamadoriDivision of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID http://orcid.org/0000-0001-6581-9648
Philipp HäneInstitute of Experimental Immunology, University of Zurich, 8057, Zurich, Switzerland.ORCID http://orcid.org/0009-0007-5197-3338
Shing KamDivision of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Florian MüllerDivision of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Sandra ProkoschDivision of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Ulrike RothermelDivision of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Yunchen WuInstitute for Immunology, University Hospital Heidelberg, Heidelberg, Germany.
Francesca BarlettaQuantitative Biology Center (QBiC), University of Tübingen, Tübingen, Germany.ORCID http://orcid.org/0009-0002-1396-2252
Stefan CzemmelQuantitative Biology Center (QBiC), University of Tübingen, Tübingen, Germany.ORCID http://orcid.org/0000-0002-9490-286X
Sven NahnsenQuantitative Biology Center (QBiC), University of Tübingen, Tübingen, Germany.ORCID http://orcid.org/0000-0002-4375-0691
Dominic HelmProteomics Core Facility, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID http://orcid.org/0000-0001-9321-2069
Martin SchneiderProteomics Core Facility, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Knut SchäkelDepartment of Dermatology, University Hospital Heidelberg, Heidelberg, Germany.ORCID http://orcid.org/0000-0001-6344-7799
Alexander EnkDepartment of Dermatology, University Hospital Heidelberg, Heidelberg, Germany.ORCID http://orcid.org/0000-0002-1816-421X
Burkhard BecherInstitute of Experimental Immunology, University of Zurich, 8057, Zurich, Switzerland. becher@immunology.uzh.ch.ORCID http://orcid.org/0000-0002-1541-7867
Mathias HeikenwälderDivision of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. mathias.heikenwaelder@med.uni-tuebingen.de.ORCID http://orcid.org/0000-0002-3135-2274

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) TRR156/2 - 246807620EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) 882424Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) 310030_188450 and 291 310030_219287
6 · The paper itself

Abstract

The understanding of platelet biology is expanding beyond their well-established role in thrombosis and hemostasis to encompass their functions in inflammation. To gain insights into the phenotype and possible platelet-subgroups in the context of type III inflammation, high-parametric single cell spectral flow cytometry was applied to a prospectively followed cohort of psoriasis patients undergoing systemic therapy. By focusing on the activation profile of platelets and their interaction with immune cells, we identify cell-surface proteins CD32

Indexed as

Blood PlateletsInflammationPsoriasisSingle-Cell AnalysisAdultDermatitis, AtopicFemaleFlow CytometryHumansMaleMiddle AgedPhenotypePlatelet ActivationProspective Studies

Identifiers

PMID41350257
PMCPMC12680767

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.